Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 21.00
+0.25 (1.20%)
Mar 24, 2026, 1:30 PM CST
Savior Lifetec Revenue
In the year 2025, Savior Lifetec had annual revenue of 1.20B TWD, down -1.28%. Savior Lifetec had revenue of 319.87M in the quarter ending December 31, 2025, with 15.50% growth.
Revenue
1.20B
Revenue Growth
-1.28%
P/S Ratio
5.36
Revenue / Employee
3.13M
Employees
384
Market Cap
6.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20B | -15.64M | -1.28% |
| Dec 31, 2024 | 1.22B | 167.05M | 15.91% |
| Dec 31, 2023 | 1.05B | -215.47M | -17.02% |
| Dec 31, 2022 | 1.27B | -478.04M | -27.41% |
| Dec 31, 2021 | 1.74B | -83.46M | -4.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.37B |
| Panion & Bf Biotech | 2.06B |
| Adimmune | 1.20B |
| Mycenax Biotech | 740.24M |
| Pharmosa Biopharm | 67.27M |
| AnnJi Pharmaceutical | 23.85M |
| Locus Cell | 5.18M |
| CHO Pharma | 3.21M |